A study of the antiresorptive activity of salmon calcitonin microspheres using cultured osteoclastic cells
- PMID: 12916936
- PMCID: PMC2784050
- DOI: 10.1208/pt030321
A study of the antiresorptive activity of salmon calcitonin microspheres using cultured osteoclastic cells
Abstract
The purpose of this study was to evaluate salmon calcitonin (sCT) microspheres in vitro for their antiresorptive activity using cultured osteoclastic cells. The antiresorptive activity of sCT-loaded microspheres, prepared from a low molecular weight hydrophilic poly (lactide-co-glycolide) polymer (PLGA), was studied using bone marrow culture cells harvested from juvenile rats and cultured on slices of devitalized bone for up to 4 weeks. The resorptive activity of osteoclastic cells was quantified in terms of number and type of resorption pits and total area of resorption. Microspheres containing 5.1% sCT released 70% peptide in 2 weeks and 88% in 4 weeks. All sCT treatments inhibited total resorptive activity. A dose-dependent decrease in resorption was observed with sCT microspheres at 2 weeks. The high dose (10 mg of microspheres) produced a 99.5% decrease in resorption at 3 weeks, while the low dose (1 mg) produced an 80% reduction. Exposure of cultures to soluble sCT and sCT-loaded microspheres caused a decrease in the number of large pits, which were the predominant type formed in control cultures. Thus, this system could serve as an in vitro method to evaluate the antiresorptive effect of PLGA-sCT microspheres.
Similar articles
-
Preparation, characterization, and in vivo evaluation of salmon calcitonin microspheres.AAPS PharmSciTech. 2001 Oct 17;2(4):22. doi: 10.1208/pt020422. AAPS PharmSciTech. 2001. PMID: 14727859 Free PMC article.
-
Adsorption of salmon calcitonin to PLGA microspheres.Pharm Res. 1995 Jul;12(7):1072-6. doi: 10.1023/a:1016278902839. Pharm Res. 1995. PMID: 7494805
-
Effects of continuous calcitonin treatment on osteoclasts derived from cocultures of mouse marrow stromal and spleen cells.J Formos Med Assoc. 2000 Feb;99(2):140-50. J Formos Med Assoc. 2000. PMID: 10770029
-
Recent advances in the preparation progress of protein/peptide drug loaded PLA/PLGA microspheres.Yao Xue Xue Bao. 2007 Jan;42(1):1-7. Yao Xue Xue Bao. 2007. PMID: 17520799 Review.
-
Calcitonin effects on osteoclastic resorption: the 'escape phenomenon' revisited.Bone Miner. 1992 Mar;16(3):174-7. doi: 10.1016/0169-6009(92)90895-k. Bone Miner. 1992. PMID: 1314121 Review. No abstract available.
Cited by
-
Materials for pharmaceutical dosage forms: molecular pharmaceutics and controlled release drug delivery aspects.Int J Mol Sci. 2010 Sep 15;11(9):3298-322. doi: 10.3390/ijms11093298. Int J Mol Sci. 2010. PMID: 20957095 Free PMC article. Review.
References
-
- Milhaud G. Etude du mecanisme de l'action hypocalcemiante de la thyrocalcitonine. CR Acad Sci Paris. 1965;261:813–816. - PubMed
-
- Kohler H. Wechselwirkung von Thyreocalcitonin und Parathormon. Schweiz med Wochenschr. 1968;98:728–728. - PubMed
-
- Munson PL. Physiology and pharmacology of thyrocalcitonin. In: Aurbach GD, editor. Handbook of Physiology. Washington, DC: American Physiological Society; 1976. pp. 443–464.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources